Get the Stockscreener App
28.28
3.48%
-1.02
After Hours:
28.28
Evolent Health Inc stock is traded at $28.28, with a volume of 1.96M.
It is down -3.48% in the last 24 hours and down -11.57% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$29.30
Open:
$29.21
24h Volume:
1.96M
Relative Volume:
0.83
Market Cap:
$3.29B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-27.73
EPS:
-1.02
Net Cash Flow:
$150.93M
1W Performance:
-5.67%
1M Performance:
-11.57%
6M Performance:
-13.75%
1Y Performance:
+3.86%
1-Day Range:
$28.17
$29.25
1-Week Range:
$27.48
$30.33
52-Week Range:
$17.98
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health's SWOT analysis: healthcare tech firm's stock navigates challenges - Investing.com
Evolent Health's SWOT analysis: healthcare tech firm's stock navigates challenges - Investing.com India
Public Employees Retirement Association of Colorado Cuts Stock Position in Evolent Health, Inc. (NYSE:EVH) - Defense World
Evolent Health's stock presents valuation opportunity, according to Barclays By Investing.com - Investing.com Canada
Engaged Capital LLC Has $78.61 Million Stock Holdings in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Truist raises Evolent Health to buy, cites rate increases - MSN
Envestnet Asset Management Inc. Sells 10,826 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Eldorado Gold (TSE:ELD) Share Price Passes Above Two Hundred Day Moving Average of $21.14 - Defense World
Mondelez takes majority stake in Chinese bakery Evirth - Inside FMCG
Evolus Inc (EOLS) may enjoy gains as insiders got busy in the recent days - Knox Daily
Evolv Technologies (NASDAQ:EVLV) Shares Down 2.9% - Defense World
EverSource Wealth Advisors LLC Raises Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Shares Gap Down to $23.57 - MarketBeat
First Light Asset Management LLC Has $27.63 Million Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
Solel Partners LP Takes $488,000 Position in Everi Holdings Inc. (NYSE:EVRI) - Defense World
Evolv Technologies Holdings Inc (EVLV) looking to reclaim success with recent performance - SETE News
Stock Market Recap: Evolus Inc (EOLS) Concludes at 15.53, a -6.16 Surge/Decline - The Dwinnex
Check out these key findings about Elevation Oncology Inc (ELEV) - SETE News
Gabelli Funds LLC Buys 93,500 Shares of Evolent Health, Inc. (NYSE:EVH) - Defense World
Evolution AB: This Bargain-Priced Compounder Has Massive Upside Potential (OTCMKTS:EVVTY) - Seeking Alpha
Lombard Odier Asset Management Europe Ltd Invests $2.51 Million in Elevance Health, Inc. (NYSE:ELV) - Defense World
Pacer Advisors Inc. Decreases Stock Position in Elevance Health, Inc. (NYSE:ELV) - Defense World
Distillate Capital Partners LLC Grows Position in Elevance Health, Inc. (NYSE:ELV) - MarketBeat
Victory Capital Management Inc. Sells 414,447 Shares of Evolent Health, Inc. (NYSE:EVH) - Defense World
Rhumbline Advisers Acquires 17,442 Shares of Evolus, Inc. (NASDAQ:EOLS) - Defense World
First Light Asset Management LLC Has $27.63 Million Stake in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evoke PLC Welcomes New Board Expertise - TipRanks
Mondelēz International acquires majority stake at cake, pastries manufacturer Evirth - MARKETECH APAC
Elevai Labs shares tumble on pricing of new stock offering - The Business Journals
Elevance Health, Inc. (NYSE:ELV) Position Boosted by Magnetar Financial LLC - Defense World
Hood River Capital Management LLC Sells 589,585 Shares of Evolent Health, Inc. (NYSE:EVH) - Defense World
Perhaps timely catching Enliven Therapeutics Inc (ELVN) would be a good idea - SETE News
Ratios in Focus: Analyzing Elevation Oncology Inc (ELEV)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Mondelēz Agrees to Acquire Chinese Bakery Company Evirth - Food Processing
Investing in Elevation Oncology Inc (ELEV) might be a great opportunity, but the stock is a bit undervalued - US Post News
XTX Topco Ltd Increases Stock Position in Evolent Health, Inc. (NYSE:EVH) - Defense World
Mondelēz buys majority stake in fast-growing Chinese cake and pastry maker - Food Dive
MDLZ to Fuel Presence in Cakes & Pastries Market With Evirth Deal - Zacks Investment Research
MDLZ to Fuel Presence in Cakes & Pastries Market With Evirth Deal - Yahoo Finance
EVTL Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Ensign Peak Advisors Inc Acquires 2,862 Shares of Elevance Health, Inc. (NYSE:ELV) - Defense World
Lombard Odier Asset Management Europe Ltd Has $3.82 Million Stake in Evolent Health, Inc. (NYSE:EVH) - Defense World
How should investors view Evolv Technologies Holdings Inc (EVLV)? - US Post News
Enovis Co. (NYSE:ENOV) Shares Acquired by Magnetar Financial LLC - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Shares Bought by Lombard Odier Asset Management Europe Ltd - MarketBeat
Evexia Lifecare shares gain as company approves funds raise via convertible warrants - India.com
Mondelēz expands presence in China’s pastry market with Evirth acquisition - FoodBev.com
Seven Eight Capital LP Makes New Investment in Evolent Health, Inc. (NYSE:EVH) - Defense World
Eleving Group Targets $34 Million From Initial Public Offering - MarketWatch
Mondelēz to buy China's Evirth, eyes expansion in fast-growing cakes and pastries - Seeking Alpha
Multibagger penny stock Evexia Lifecare declares preferential issue at ₹3.60 per share. Details here | Stock Market News - Mint
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):